Are You Ready for Serialization Implementation?
Serialization implementation is probably on your radar already if you’re an executive at an emerging Biopharma company. Manufacturers need to…
Perspective
Serialization implementation is probably on your radar already if you’re an executive at an emerging Biopharma company. Manufacturers need to…
Perspective
We often see clients incurring high duties on importing key starting materials into the US. For emerging companies conducting R&D,…
Perspective
Pharmaceutical manufacturers currently share transaction data with their trading partners at the lot level. The Drug Supply Chain Security Act…
Perspective
Per DSCSA, the U.S. pharmaceutical industry must be exchanging EPCIS data at the serialized package level by November 27,…
Perspective
While the Drug Supply Chain Security Act (DSCSA) does not require manufacturers to send package-level serialization data downstream until November…
Perspective
The COVID-19 pandemic exposed the risks and fragility inherent in global pharmaceutical and biotechnology supply chains. This isn’t really news though. For…
Perspective
Today’s biopharmaceutical supply chains often stretch around the world. Key starting materials (KSM) and API originate more frequently from Asia.…
Perspective
The COVID-19 pandemic and resulting economic crisis exposed the vulnerabilities of both domestic and global supply chains across multiple industries.…
Perspective
On February 24, 2021, President Biden signed an Executive Order on America’s Supply Chains (EO) as a step toward building more secure, robust and resilient…
Perspective
The current pandemic is severely impacting life science supply chains. There are supply delays, constrained transportation and cold storage, and…
Converge Consulting exclusively serves the Life Sciences industry with strategy, operations, and execution expertise. We are based in the Boston/Cambridge area, one of the most active hubs for Life Sciences best practices in the world.